Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461538 | SCV000542881 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2016-10-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170515 | SCV001333098 | uncertain significance | Cardiomyopathy | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002393084 | SCV002671949 | uncertain significance | Cardiovascular phenotype | 2019-09-13 | criteria provided, single submitter | clinical testing | The p.G25086R variant (also known as c.75256G>C), located in coding exon 185 of the TTN gene, results from a G to C substitution at nucleotide position 75256. The glycine at codon 25086 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003139634 | SCV003826750 | uncertain significance | not provided | 2019-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003139634 | SCV005685671 | uncertain significance | not provided | 2024-07-23 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; Has not been previously published as pathogenic or benign to our knowledge |